Doxorubicin Induced Cardiomyopathy Recruiting Phase 2 / 3 Trials for Atorvastatin (DB01076)

IndicationStatusPhase
DBCOND0078390 (Doxorubicin Induced Cardiomyopathy)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05792293Role of Statin Therapy in Prevention of Anthracycline-Induced CardiotoxicityPrevention